8-K
Current Report
Cocrystal Pharma, Inc. Filed Acc 0001521536-11-000361
New debt or obligation · Debt accelerated · Unregistered share sale
- Item 2.03 Creation of a direct financial obligation
- Item 2.04 Triggering events that accelerate or increase an obligation
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading q1100220_8k-biozone.htm…